Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025

1 week ago 6
ARTICLE AD BOX
Read Entire Article
  1. Homepage
  2. Finance
  3. Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025

Related

White House seeks budget cuts for Justice Department law enforcement offices, sources say

White House seeks budget cuts for Justice Department law enf...

2 hours ago 0
Rimini Street EVP Steven Hershkowitz sells $86,724 in stock

Rimini Street EVP Steven Hershkowitz sells $86,724 in stock

2 hours ago 0
Smart Digital Group Prices 1.5M Share IPO at $4/sh

Smart Digital Group Prices 1.5M Share IPO at $4/sh

2 hours ago 0
RIGHT SIDEBAR TOP AD

Trending

1. judge dismisses
2. juju watkins
3. stephanie ruhle
4. camila cabello
5. blue jays
6. toronto
7. isaiah stewart
8. cory booker
9. max pacioretty
10. jalen brunson

Popular

What we know about the New York City helicopter crash that killed 6 people

What we know about the New York City helicopter crash that k...

2 weeks ago 93
Paxton's challenge isn't the only one worrying Senate Republicans

Paxton's challenge isn't the only one worrying Senate Republ...

2 weeks ago 92
Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds slim Masters lead at midway point

Rory McIlroy, Bryson DeChambeau surge; Justin Rose holds sli...

2 weeks ago 79
Biden reemerges on the attack, but doesn’t mention Trump

Biden reemerges on the attack, but doesn’t mention Trump

2 weeks ago 74
From classifying immigrants as dead to deportation: A guide to actions on Trump immigration policies

From classifying immigrants as dead to deportation: A guide ...

2 weeks ago 74
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Powerbits - breaking news today 2025. All rights are reserved